Calmodulin binds and stabilizes the regulatory enzyme, CTP:Phosphocholine cytidylyltransferase

被引:28
作者
Chen, Bill. B.
Mallampalli, Rama K.
机构
[1] Univ Iowa, Div Pulm & Crit Care, Dept Internal Med, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA
[2] Univ Iowa, Dept Biochem, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA
[3] Univ Iowa, Dept Vet Affairs Med Ctr, Dept Vet Affairs Med Ctr, Iowa City, IA 52242 USA
关键词
D O I
10.1074/jbc.M706472200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
CTP: phosphocholine cytidylyltransferase (CCT alpha) is a proteolytically sensitive enzyme essential for production of phosphatidylcholine, the major phospholipid of animal cell membranes. The molecular signals that govern CCT alpha protein stability are unknown. An NH2-terminal PEST sequence within CCT alpha did not serve as a degradation signal for the proteinase, calpain. Calmodulin (CaM) stabilized CCT alpha from calpain proteolysis. Adenoviral gene transfer of CaM in cells protected CCT alpha, whereas CaM small interfering RNA accentuated CCT alpha degradation by calpains. CaM bound CCT alpha as revealed by fluorescence resonance energy transfer and two-hybrid analysis. Mapping and site-directed mutagenesis of CCT alpha uncovered a motif (LQERVDKVK) harboring a vital recognition site, Gln(243), whereby CaM directly binds to the enzyme. Mutagenesis of CCT alpha Gln(243) not only resulted in loss of CaM binding but also led to complete calpain resistance in vitro and in vivo. Thus, calpains and CaM both access CCT alpha using a structurally similar molecular signature that profoundly affects CCT alpha levels. These data suggest that CaM, by antagonizing calpain, serves as a novel binding partner for CCT alpha that stabilizes the enzyme under proinflammatory stress.
引用
收藏
页码:33494 / 33506
页数:13
相关论文
共 45 条
[31]   Calmodulin antagonist W-7 inhibits de novo synthesis of cholesterol and suppresses secretion of de novo synthesized and preformed lipids from cultured hepatocytes [J].
Rasouli, M ;
Trischuk, TC ;
Lehner, R .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 2004, 1682 (1-3) :92-101
[32]   PEST sequences and regulation by proteolysis [J].
Rechsteiner, M ;
Rogers, SW .
TRENDS IN BIOCHEMICAL SCIENCES, 1996, 21 (07) :267-271
[33]   Sequence motifs for calmodulin recognition [J].
Rhoads, AR ;
Friedberg, F .
FASEB JOURNAL, 1997, 11 (05) :331-340
[34]   CTP:phosphocholine cytidylyltransferase α is a cytosolic protein in pulmonary epithelial cells and tissues [J].
Ridsdale, R ;
Tseu, I ;
Wang, JX ;
Post, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (52) :49148-49155
[35]   The PEST domain of IκBα is necessary and sufficient for in vitro degradation by μ-calpain [J].
Shumway, SD ;
Maki, M ;
Miyamoto, S .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (43) :30874-30881
[36]   The structure of calpain [J].
Sorimachi, H ;
Suzuki, K .
JOURNAL OF BIOCHEMISTRY, 2001, 129 (05) :653-664
[37]   Sp1 is a co-activator with Ets-1, and net is an important repressor of the transcription of CTP:Phosphocholine cytidylyltransferase α [J].
Sugimoto, H ;
Okamura, K ;
Sugimoto, S ;
Satou, M ;
Hattori, T ;
Vance, DE ;
Izumi, T .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (49) :40857-40866
[38]   Mutation of Tyr138 disrupts the structural coupling between the opposing domains in vertebrate calmodulin [J].
Sun, H ;
Yin, D ;
Coffeen, LA ;
Shea, MA ;
Squier, TC .
BIOCHEMISTRY, 2001, 40 (32) :9605-9617
[39]   Induction of CCAAT/enhancer-binding protein (C/EBP)-homologous protein/growth arrest and DNA damage-inducible protein 153 expression during inhibition of phosphatidylcholine synthesis is mediated via activation of a C/EBP-activating transcription factor-responsive element [J].
van der Sanden, MHM ;
Meems, H ;
Houweling, M ;
Helms, JB ;
Vaandrager, AB .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (50) :52007-52015
[40]   Proteolytic cleavage of inducible nitric oxide synthase (iNOS) by calpain I [J].
Walker, G ;
Pfeilschifter, J ;
Otten, U ;
Kunz, D .
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 2001, 1568 (03) :216-224